Who owns BridgeBio Oncology Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BBOT from SEC Form 13F filings across 89 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 89 institutions disclosed 60.3M shares of BridgeBio Oncology Therapeutics, Inc. worth $247.1M — about 75.2% of shares outstanding; the largest disclosed holder is Cormorant Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
89
13F holders
$247.1M
value, 2026 filers
75.2%
of shares outstanding (60.3M sh)
33
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BBOT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 17.9M | $73.3M | 4.9% | 22.3% | 0.0% |
| 2 | BlackRock, Inc. | 4.0M | $16.4M | 0.0% | 5% | +86.2% |
| 3 | Omega Fund Management, LLC | 3.3M | $13.5M | 10.8% | 4.1% | 0.0% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 3.1M | $12.9M | 0.2% | 3.9% | -35.8% |
| 5 | Alphabet Inc. | 2.8M | $11.6M | 0.0% | 3.5% | 0.0% |
| 6 | CITADEL ADVISORS LLC | 2.7M | $11.1M | 0.0% | 3.4% | +3.0% |
| 7 | ENAVATE SCIENCES GP, LLC | 2.6M | $10.8M | 3.8% | 3.3% | 0.0% |
| 8 | REGENTS OF THE UNIVERSITY OF CALIFORNIANEW | 2.5M | $10.3M | 0.2% | 3.1% | new |
| 9 | ARMISTICE CAPITAL, LLC | 2.3M | $9.3M | 0.1% | 2.8% | +28.3% |
| 10 | NOVO HOLDINGS A/S | 2.3M | $9.2M | 0.6% | 2.8% | 0.0% |
| 11 | Laurion Capital Management LP | 2.0M | $8.2M | 0.1% | 2.5% | 0.0% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $8.2M | 0.0% | 2.5% | -0.7% |
| 13 | WELLINGTON MANAGEMENT GROUP LLP | 1.4M | $5.9M | 0.0% | 1.8% | -48.7% |
| 14 | Aisling Capital Management LP | 1.0M | $4.1M | 1.4% | 1.3% | 0.0% |
| 15 | STATE STREET CORP | 893,262 | $3.7M | 0.0% | 1.1% | -13.8% |
| 16 | EcoR1 Capital, LLC | 889,607 | $3.6M | 0.2% | 1.1% | -68.5% |
| 17 | Catalio Capital Management, LP | 699,532 | $2.9M | 0.5% | 0.9% | +119.7% |
| 18 | Opaleye Management Inc. | 630,000 | $2.6M | 0.3% | 0.8% | -10.0% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 556,989 | $2.3M | 0.0% | 0.7% | -10.5% |
| 20 | MARSHALL WACE, LLPNEW | 482,935 | $2.0M | 0.0% | 0.6% | new |
| 21 | SPHERA FUNDS MANAGEMENT LTD. | 464,480 | $1.9M | 0.3% | 0.6% | +0.8% |
| 22 | Granahan Investment Management, LLC | 437,004 | $1.8M | 0.1% | 0.5% | -21.8% |
| 23 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 400,000 | $1.6M | 0.0% | 0.5% | 0.0% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 349,576 | $1.4M | 0.0% | 0.4% | +82.9% |
| 25 | PRICE T ROWE ASSOCIATES INC /MD/ | 298,798 | $1.2M | 0.0% | 0.4% | -0.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.